Association of NTRK3 and its interaction with NGF suggest an altered cross-regulation of the neurotrophin signaling pathway in eating disorders
Josep M. Mercader(Institut d'Investigació Biomédica de Bellvitge), Xavier Estivill(Barcelona Biomedical Research Park), Fernando Fernández‐Aranda(Massachusetts General Hospital), Mara Dierssen(Centre for Biomedical Network Research on Rare Diseases), Sandro Sorbi(University of Florence), Anna Puig(Universitat Pompeu Fabra), Marta Ribasés(Universitat Autònoma de Barcelona), Xavier Gallego(Centre for Genomic Regulation), Mónica Gratacòs(Essen University Hospital), Lucía Romo(Université Paris Cité), Elena Cellini(University of Florence), Ester Saus(Instituto de Salud Carlos III), Philip Gorwood(Inserm), Johannes Hebebrand(Philipps University of Marburg), Audrey Versini(Inserm), Laura Forcano(Instituto de Salud Carlos III), Valdo Ricca(University of Florence), Benedetta Nacmias(University of Florence), Rafael de Cid(Centre National de Recherche en Génomique Humaine), Claudette Boni(Inserm), Juan R. González(Universitat Autònoma de Barcelona), Anna Carreras(Instituto de Salud Carlos III), Geòrgia Escaramís(Universitat Pompeu Fabra), Zaida Agüera(Instituto de Salud Carlos III), Mónica Bayés(Centro Nacional de Análisis Genómico), Anke Hinney(Philipps University of Marburg)
Cited by 57
Related Papers
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
|Nature Medicine|2017|1.6k
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
|Nature|2011|1.5k
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
|Nature Reviews Drug Discovery|2012|1.3k
The consequences of the COVID-19 pandemic on mental health and implications for clinical practice
|European Psychiatry|2020|1.2k